Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Skin stem cells were turned into heart cells using a chemical, suggesting a new way to treat heart attacks.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Glycerol may improve wound healing and prevent keloids, a device can measure itch intensity, male pattern baldness is highly heritable, and fumaric acid esters may work for psoriasis by causing cell death in T cells.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Benign follicular mucinosis involves immune cells attacking hair follicles.

Mice can grow new hair follicles after skin wounds through a process not involving existing hair stem cells, but requiring more research to understand fully.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Immune cells affect hair growth and could lead to new hair loss treatments.

FoxN1 overexpression in young mice harms immune cell and skin development.

New hair can grow from large wounds in mice, but less so as they age, involving reprogramming of skin cells and specific molecular pathways.

ILC1 cells contribute to hair loss in alopecia areata.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Fetal skin has unique immune cells different from adult skin.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

Non-immune dermal cells dominate, epidermal cells increase after day 9, and certain immune cells persist beyond inflammation in wound-induced hair follicle regeneration.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.